Pancreatic serous cystadenoma with a high 68 Ga DOTATOC-uptake mimicking a pancreatic NET
International Journal of Hepatobiliary and Pancreatic Diseases · 2022
DOI: 10.5348/100097z04eb2022eb ↗Abstract
Introduction: 68Ga-DOTATOC positron emission tomography (PET) has replaced octreotide scintigraphy as method of choice in detecting and staging most neuroendocrine tumors (NETs). With a better signal-to-noise ratio and improved spatial resolution, sensitivity is increased. However, several non-NETs express surface somatostatin receptors, challenging the positive predictive value of a DOTATOC scan regarding a NET diagnosis. This is of particular concern in pancreas as NET is a frequent differential diagnosis, as is a variety of cystic neoplasms increasingly often diagnosed as incidental findings. Case Report: A 66-year-old man was diagnosed with an asymptomatic cystic tumor in the pancreatic neck. At computed tomography scan (CT) a 4 cm P-NET was suspected as an incidental finding. The diagnosis was supported by a positive 68Ga-DOTATOC scan, with a high DOTATOC-uptake in the pancreatic tumor and in a local interaortocaval node. The tumor was radically resected. At pathologic examination a pancreatic serous cystadenoma (SCN) was unexpectedly diagnosed, with the regional nodes proven only to harbor granulomatous inflammation. Conclusion: A rare case of a 68Ga-DOTATOC positive SCN is reported. Diagnostic workup was confounded by a local node exhibiting a high DOTATOC-uptake. Radiologists, nuclear medicine physicians, and pancreatic surgeons must be aware of this diagnostic pitfall to avoid unnecessary surgical procedures.
EUVIMED